Literature DB >> 2794752

Qinghaosu-mediated oxidation in normal and abnormal erythrocytes.

M D Scott1, S R Meshnick, R A Williams, D T Chiu, H C Pan, B H Lubin, F A Kuypers.   

Abstract

Qinghaosu, a potent antimalarial agent, has recently been shown to act via oxidative mechanisms. Hence, we have investigated what effect qinghaosu has on cellular oxidation in normal and oxidant-sensitive red blood cells (RBCs). At 500 mumol/L, qinghaosu was found to directly alter red cell deformability (DI) in both normal (hemoglobin AA) and abnormal (hemoglobins SS, AE, and EE) RBCs, with the maximum DI being 70% to 80% of that of untreated RBCs. Although concentrations of less than or equal to 200 mumol/L qinghaosu had a minimal effect on the maximum DI, qinghaosu was found to act as an efficient prooxidant at these concentrations. Cellular deformability was lost more rapidly in response to exogenous oxidants in the qinghaosu-treated RBCs than in control cells. Hemoglobin SS and EE RBCs pretreated with qinghaosu demonstrated a much more rapid decrease in cellular deformability than did the control RBCs in response to exogenous oxidants. Additionally, qinghaosu resulted in a dose-dependent increase in red cell lysis and methemoglobin generation while decreasing reduced glutathione concentration. As a consequence of qinghaosu challenge, a decrease in unsaturated fatty acids was noted. Deoxyqinghaosu, which lacks the endoperoxide bridge and is pharmacologically inactive, did not affect cellular deformability and did not function as a prooxidant. Additionally, deoxyqinghaosu had no effect on fatty acid composition, red cell lysis, methemoglobin generation, or reduced glutathione concentration. In conclusion, although the oxidative effects of qinghaosu on uninfected erythrocytes were only seen at concentrations much greater than that necessary for antimalarial activity, these results confirm the proposition that qinghaosu may act via oxidative mechanisms. Furthermore, qinghaosu-mediated oxidation was significantly increased in erythrocytes characterized by enhanced oxidant sensitivity caused by unstable hemoglobins.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2794752

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  7 in total

1.  Artemisinin activity against Plasmodium falciparum requires hemoglobin uptake and digestion.

Authors:  Nectarios Klonis; Maria P Crespo-Ortiz; Iveta Bottova; Nurhidanatasha Abu-Bakar; Shannon Kenny; Philip J Rosenthal; Leann Tilley
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-27       Impact factor: 11.205

Review 2.  Artemisinin and the antimalarial endoperoxides: from herbal remedy to targeted chemotherapy.

Authors:  S R Meshnick; T E Taylor; S Kamchonwongpaisan
Journal:  Microbiol Rev       Date:  1996-06

3.  Simple in vitro assay for determining the sensitivity of Plasmodium vivax isolates from fresh human blood to antimalarials in areas where P. vivax is endemic.

Authors:  Bruce M Russell; Rachanee Udomsangpetch; Karl H Rieckmann; Barbara M Kotecka; Russell E Coleman; Jetsumon Sattabongkot
Journal:  Antimicrob Agents Chemother       Date:  2003-01       Impact factor: 5.191

Review 4.  Discovery, mechanisms of action and combination therapy of artemisinin.

Authors:  Liwang Cui; Xin-zhuan Su
Journal:  Expert Rev Anti Infect Ther       Date:  2009-10       Impact factor: 5.091

5.  Resistance to artemisinin of malaria parasites (Plasmodium falciparum) infecting alpha-thalassemic erythrocytes in vitro. Competition in drug accumulation with uninfected erythrocytes.

Authors:  S Kamchonwongpaisan; G Chandra-ngam; M A Avery; Y Yuthavong
Journal:  J Clin Invest       Date:  1994-02       Impact factor: 14.808

6.  Iron-dependent free radical generation from the antimalarial agent artemisinin (qinghaosu).

Authors:  S R Meshnick; Y Z Yang; V Lima; F Kuypers; S Kamchonwongpaisan; Y Yuthavong
Journal:  Antimicrob Agents Chemother       Date:  1993-05       Impact factor: 5.191

Review 7.  Oxidative stress in malaria.

Authors:  Sandro Percário; Danilo R Moreira; Bruno A Q Gomes; Michelli E S Ferreira; Ana Carolina M Gonçalves; Paula S O C Laurindo; Thyago C Vilhena; Maria F Dolabela; Michael D Green
Journal:  Int J Mol Sci       Date:  2012-12-03       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.